Form 4: ClearPoint Neuro COO Mazin Sabra Reports Stock Transactions

ClearPoint Neuro's Chief Operating Officer, Mazin Sabra, reports the acquisition and disposal of company stock and restricted stock units on March 6, 2024.

Summary

• On March 6, 2024, Mazin Sabra, the Chief Operating Officer of ClearPoint Neuro, Inc. (CLPT), engaged in transactions involving the company's stock.
• Sabra acquired 6,913 shares of common stock through the vesting of restricted stock units.
• Simultaneously, Sabra disposed of 3,463 shares to cover tax withholding obligations related to the vesting of the restricted stock units at a price of $6.24 per share.
• Following these transactions, Sabra directly owns 43,889 shares of ClearPoint Neuro common stock.
• Sabra also holds 27,654 restricted stock units, each representing a contingent right to receive one share of CLPT common stock.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing reflecting standard executive compensation practices. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock. It's a standard practice for officers of publicly traded companies.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they involve a relatively small number of shares.
• The vesting of restricted stock units incentivizes the COO to contribute to the company's success.

Key Dates